Strata Critical Medical (SRTA) Stock: Buy, Sell, or Hold?
SRTA - Strata Critical Medical, Inc. Class A Common Stock
$4.73
-0.10 (-2.07%)
▼
5d:
-11.26%
30d:
-12.24%
90d:
-13.05%
WAIT
LOW Confidence
Analysis Updated: Oct 2, 2026 12:00 AM ET
Earnings: Nov 09, 2026
Get Alerted When SRTA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: SRTA is down 11.3% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: SRTA is down 11.3% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: SRTA is currently trading at $4.73, which is considered oversold relative to its 30-day fair value range of $5.07 to $5.76. From a valuation perspective, the stock is trading at a premium (Forward PE: 1433.3) compared to its historical average (62.4). At these levels, the market is pricing in 184.2% annual earnings growth. This is a high bar to clear, indicating the stock may be priced for perfection.
Technical Outlook: Technically, SRTA is in a downtrend. The price is currently testing key support at $4.71. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: SRTA scores 26/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $9.56 (+102.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, SRTA is in a downtrend. The price is currently testing key support at $4.71. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: SRTA scores 26/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $9.56 (+102.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$5.07 -
$5.76
Company Quality Score
37/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
52.4%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (26/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 102.2% below Wall St target ($9.56)
- BEARISH: Market expects 184.2% growth - appears too optimistic based on history
- WARNING: Composite score 37/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$5.07 -
$5.76
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$4.71
Resistance Level
$5.52
Current Trend
Downtrend
Technical data as of
Oct 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
1433.33
Wall Street Target
$9.56
(+102.2%)
Revenue Growth (YoY)
60.7%
Profit Margin
15.7%
Valuation Premium vs History
+184.2% premium
PE vs Historical
1433.3 vs 62.4
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+184.2%
(market-implied from PE analysis)
1-Year Target
$7.09
(+50%)
2-Year Target
$10.64
(+125%)
3-Year Target
$15.96
(+238%)
3-Yr Target (if PE normalizes)
(PE: 1433→62)
PE COMPRESSION
$0.69
(-85%)
Significant PE compression expected
Share & Embed Analysis
Last updated: October 03, 2026 12:28 PM ET
Data refreshes hourly during market hours. Next update: 1:28 PM
Data refreshes hourly during market hours. Next update: 1:28 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SRTA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
THC
Tenet Healthcare Corpora… |
STRONG BUY
22 analysts |
$285 | 61 BUY |
|
HCA
HCA Healthcare, Inc. |
BUY
25 analysts |
$454 | 48 HOLD |
|
EHC
Encompass Health Corp |
STRONG BUY
12 analysts |
$148 | 55 HOLD |
|
ADUS
Addus HomeCare Corporati… |
STRONG BUY
11 analysts |
$134 | 67 BUY |
|
OPCH
Option Care Health Inc |
STRONG BUY
10 analysts |
$29 | 62 BUY |